Aeolus Pharmaceuticals, Inc.
AOLSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$15209
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Aeolus Pharmaceuticals, Inc. (AOLS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AOLS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2016-09 | 2015-09 | 2014-09 | 2013-09 | 2012-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.08M | $3.11M | $9.63M | $3.93M | $7.29M |
| Cost of Revenue | $2.88M | $3.51M | $6.97M | $3.36M | $0.00M |
| Gross Profit | ($0.81M) | ($0.40M) | $2.67M | $0.57M | $7.29M |
| Gross Margin %(computed) | -38.78% | -12.79% | 27.67% | 14.46% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $2.88M | $3.51M | $6.97M | $3.36M | $6.47M |
| G&A Expenses | $2.47M | $2.23M | $2.70M | $3.27M | $3.20M |
| Total Operating Expenses | $5.35M | $5.74M | $9.71M | $3.27M | $9.66M |
| Operating Income | ($3.27M) | ($2.63M) | ($0.08M) | ($2.70M) | ($2.37M) |
| Operating Margin %(computed) | -157.66% | -84.41% | -0.83% | -68.69% | -32.51% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.28M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($3.56M) | ($2.63M) | ($0.08M) | ($3.21M) | $1.70M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($3.56M) | ($2.63M) | ($0.08M) | ($3.21M) | $1.70M |
| Net Margin %(computed) | -171.39% | -84.47% | -0.83% | -81.67% | 23.28% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $-0.02 | $-0.00 | $-0.03 | $0.01 |
| Wtd Avg Shares | 148.67M | 135.88M | 134.67M | 106.55M | 61.59M |
| EBITDA | ($3.27M) | ($2.63M) | ($0.08M) | ($2.69M) | ($2.36M) |
| EBITDA Margin %(computed) | -157.66% | -84.41% | -0.83% | -68.53% | -32.41% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Aeolus Pharmaceuticals, Inc. data
About Aeolus Pharmaceuticals, Inc. (AOLS) Income Statement
Aeolus Pharmaceuticals, Inc. (AOLS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2016, AOLS reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -38.78%), and net income of ($0.00B) — a net profit margin of -171.39%.
Frequently asked questions
AOLS · 4 questionsAeolus Pharmaceuticals, Inc. (AOLS) reported revenue of $0.00B for 2016, down 33.3% year-over-year.
AOLS revenueAOLS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09